Table I.
Clinicopathological characteristics of patients with primary breast cancer.
| Characteristics | n (%) |
|---|---|
| Age (years) | |
| Average (range) | 55.3 (31–88) |
| <50 | 82 (39) |
| ≥50 | 126 (61) |
| Sex | |
| Male | 0 (0) |
| Female | 208 (100) |
| Metastatic lymph nodes | |
| 0 | 128 (62) |
| 1–3 | 56 (27) |
| ≥4 | 24 (11) |
| Lymphovascular invasion | |
| − | 84 (40) |
| + | 124 (60) |
| Hormone status | |
| +/+ and +/− | 157 (75) |
| −/− | 51 (25) |
| Human epidermal growth factor receptor 2 | |
| + | 16 (8) |
| − | 192 (92) |
| Triple negative | 33 (16) |
| pT stage | |
| 1 | 116 (56) |
| 2 | 83 (40) |
| 3 | 3 (1) |
| 4 | 6 (3) |
| Pathological stage | |
| I | 82 (39) |
| II | 120 (58) |
| III | 6 (3) |
| Local recurrence | |
| − | 202 (97) |
| + | 6 (3) |
| Remote recurrence | |
| − | 192 (92) |
| + | 16 (8) |
Total number of patients, 208. Hormone status, estrogen and progesterone receptor status; TNM, tumor-node-metastasis; pT, pathological tumor stage.